You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 49483-0682


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 49483-0682

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

49483-0682 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 49483-0682

Introduction

To conduct a thorough market analysis and price projection for the drug with the National Drug Code (NDC) 49483-0682, it is crucial to understand the drug's characteristics, market context, and relevant regulatory frameworks.

Drug Characteristics

The NDC 49483-0682 corresponds to a specific drug product, but the exact details of this NDC are not provided in the sources. However, we can infer some general information based on similar NDCs.

  • Labeler and Product: The labeler code (the first segment of the NDC) identifies the manufacturer or distributor. For example, the labeler code "49483" is associated with Time Cap Laboratories, Inc., as seen in another product with a similar NDC[1].
  • Dosage Form and Strength: The product code (the second segment) specifies the strength, dosage form, and formulation. For instance, another product from the same labeler is a low-dose aspirin tablet with 81 mg of aspirin per tablet[1].

Market Context

Pharmaceutical Market Trends

The pharmaceutical market is dynamic, influenced by various factors such as regulatory changes, technological advancements, and market demand.

  • AI and Health Tech: The adoption of artificial intelligence (AI) in pharmaceutical operations is expected to increase significantly in 2025. This includes using AI for clinical development, data science models, and generating reports to aid in decision-making[3].
  • Immunotherapies and Targeted Therapies: In specific disease areas like Non-Small Cell Lung Cancer (NSCLC), immunotherapies and targeted therapies are gaining prominence. Drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, driven by their efficacy in first-line and second-line treatments[4].

Pricing Mechanisms

Pricing in the pharmaceutical market is complex and regulated.

  • 340B Ceiling Price: For drugs sold to 340B covered entities, the ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) and then adjusting for package size and case pack size[2].
  • Generic and Branded Drugs: The market is also influenced by the lifecycle of drugs, including patent expirations and the introduction of generics. For example, the sales of patented drugs like Tarceva and Alimta are expected to decline significantly due to patent expirations, while generics are expected to fill the gap[4].

Regulatory Framework

National Drug Code (NDC)

The NDC is a critical identifier for drug products, ensuring each product is uniquely identified.

  • NDC Structure: The NDC consists of a 10-digit, three-segment number that identifies the labeler, product, and package size. This system is managed by the FDA and ensures compliance with drug listing regulations[5].

Price Projections

Given the lack of specific data on the drug with NDC 49483-0682, we can make some general observations based on similar products and market trends.

Factors Influencing Price

  • Market Demand: The demand for the drug, influenced by its therapeutic area and competition, will significantly impact its pricing.
  • Regulatory Environment: Prices may be affected by regulatory requirements such as those under the 340B program or other pricing mechanisms.
  • Generic Competition: If the drug faces generic competition, its price is likely to decrease over time.
  • Technological Advancements: The integration of AI and other health technologies could influence production costs and efficiency, potentially affecting pricing.

Example Pricing Scenarios

  • Immunotherapies in NSCLC: Drugs like Keytruda and Opdivo, which are projected to achieve high sales figures, are priced based on their efficacy and market demand. For instance, Keytruda is expected to contribute $5.2 billion to the NSCLC market by 2025[4].
  • OTC Drugs: For over-the-counter (OTC) drugs like aspirin, prices are generally lower and more stable. However, they can still be influenced by market competition and regulatory changes.

Key Takeaways

  • Unique Identification: The NDC is crucial for identifying and tracking drug products in the market.
  • Market Trends: The pharmaceutical market is heavily influenced by technological advancements, regulatory changes, and market demand.
  • Pricing Mechanisms: Prices are determined by a combination of factors including regulatory requirements, market competition, and the drug's lifecycle.
  • Generic and Branded Dynamics: The introduction of generics can significantly impact the pricing and sales of branded drugs.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique 10-digit code that identifies a drug product, including the labeler, product, and package size. It is used to ensure compliance with FDA regulations and to track drug products in the market[5].

Q: How does the 340B program affect drug pricing? A: The 340B program sets a ceiling price for drugs sold to covered entities by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) and adjusting for package size and case pack size[2].

Q: What impact do generic drugs have on the pharmaceutical market? A: Generic drugs can significantly reduce the sales of branded drugs by offering a cheaper alternative, especially after the branded drug's patent expires[4].

Q: How is AI expected to influence the pharmaceutical industry in 2025? A: AI is expected to play a larger role in clinical development, data science models, and generating reports to aid in decision-making within the pharmaceutical industry[3].

Q: What are some key drivers of the NSCLC market? A: The NSCLC market is driven by the increasing use of immunotherapies and targeted therapies, such as Keytruda, Opdivo, and Tecentriq, particularly in first-line and second-line treatments[4].

Sources

  1. FDA Report: NDC 49483-481 Oral Tablet, Coated LOW DOSE ASPIRIN Drug.
  2. HRSA: NDC Product Details - Log into 340B OPAIS.
  3. Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
  4. Drug-Dev: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
  5. FDA: National Drug Code Database Background Information.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.